Metraipolis › archive › dc_dc59b829eb18
Value contribution of trifluridine/tipiracil with bevacizumab for the treatment of metastatic colorectal cancer in Catalonia using a multicriteria decision… — Europe PMC PMID:41415036
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41415036
- DOI
- 10.1080/20523211.2025.2567970
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T09:17:26.586Z
- SHA-256 of the archived text
0849869010bb88e2969d92b7bfa161a8893445b69a9b987549748847435b821c- Stable URL of this page
https://metraipolis.com/documento/dc_dc59b829eb18
How to cite
Value contribution of trifluridine/tipiracil with bevacizumab for the treatment of metastatic colorectal cancer in Catalonia using a multicriteria decision… — Europe PMC PMID:41415036 — Europe PMC (en), https://europepmc.org/article/MED/41415036 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dc59b829eb18 (Metraipolis archive dc_dc59b829eb18, sha256 0849869010bb88e2969d92b7bfa161a8893445b69a9b987549748847435b821c)
BibTeX
@misc{dcdc59b829eb18,
title = {Value contribution of trifluridine/tipiracil with bevacizumab for the treatment of metastatic colorectal cancer in Catalonia using a multicriteria decision… — Europe PMC PMID:41415036},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41415036},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dc59b829eb18; sha256 0849869010bb88e2969d92b7bfa161a8893445b69a9b987549748847435b821c},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41415036. Agents can read the archived copy with the MCP tool read_document.